☆ 4.6 Review

Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January-December 2020

BMJ OPEN (2023)

Related references

Note: Only part of the references are listed.

Article Infectious Diseases

Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID-19 pandemic

Isabel Bergeri et al.

Summary: This article introduces the rapid development and global promotion of UNITY studies during the COVID-19 pandemic to support early investigations for appropriate public health actions. Results show that the widespread adoption of UNITY protocols across all WHO regions addresses subnational and national needs to support local public health decision-making to prevent and control the pandemic.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2022)

Add to Collection

Article Pediatrics

Age-dependent seroprevalence of SARS-CoV-2 antibodies in school-aged children from areas with low and high community transmission

Lise Boey et al.

Summary: SARS-CoV-2 infection rates in children vary by region, and children who have contact with confirmed cases, participate in extracurricular activities, or have caregivers who are healthcare workers are at higher risk of seropositivity. In areas with high community transmission, infection rates in children aged 6-12 years and 12-15 years are similar.

EUROPEAN JOURNAL OF PEDIATRICS (2022)

Add to Collection

Review Medicine, General & Internal

Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies

Isabel Bergeri et al.

Summary: Global seroprevalence of SARS-CoV-2 infection has increased over time with regional variation. Estimates of COVID-19 infections based on seroprevalence data far exceed reported cases.

PLOS MEDICINE (2022)

Add to Collection

Letter Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Adults in Madrid, Spain

Vicente Soriano et al.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors

Christian Erikstrup et al.

Summary: This study aimed to estimate previous SARS-CoV-2 infections and the population-based IFR through nationwide real-time seroprevalence surveying among Danish blood donors. The seroprevalence was found to be 1.9% and the estimated IFR in patients <70 years was 89 per 100,000 infections.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Virology

The scar of a pandemic: Cumulative incidence of COVID-19 during the first trimester of pregnancy

Stefano Cosma et al.

Summary: Data on prevalence and outcomes of COVID-19 during the first trimester of pregnancy are limited. A study found a 10.1% cumulative incidence of COVID-19 during the first trimester, with a high proportion of asymptomatic cases and higher symptom prevalence in SARS-CoV-2 positive patients. Screening for COVID-19 in early pregnancy is essential for maternal-fetal health surveillance programs in epidemic areas.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Review Infectious Diseases

SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis

Ali Rostami et al.

Summary: The study revealed significant variations in SARS-CoV-2 seroprevalence among different geographic regions, possibly related to income levels, human development indices, geographic latitudes, and climates. It was estimated that approximately 263.5 million individuals had been exposed or infected globally by 2020.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Article Public, Environmental & Occupational Health

SARS-CoV-2 Antibody Seroprevalence in Industry Workers in Split-Dalmatia and Sibenik-Knin County, Croatia

Ivan Jerkovic et al.

Summary: The study found relatively low seroprevalence of SARS-CoV-2 antibodies in Croatian industrial workers, with a slightly higher positivity rate in Split facility compared to Knin facility.

JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2021)

Add to Collection

Article Infectious Diseases

Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study

Wan Ni Chia et al.

Summary: The study investigated the dynamics of neutralising antibody response in patients who have recovered from COVID-19, finding great variations and suggesting that predicting immune longevity can only be accurately determined at the individual level. The findings emphasize the importance of public health and social measures in the ongoing pandemic outbreak response, and may have implications for the longevity of immunity after vaccination.

LANCET MICROBE (2021)

Add to Collection

Article Infectious Diseases

Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May-June 2020): implications for a testing protocol in asymptomatic individuals and estimation of the rate of undetected cases

Dietrich Mack et al.

Summary: Seroprevalence among elite professional football players and staff in Germany was around 2% with a high rate of undetected infections, possibly eight to ten times higher than reported. Moderate correlation was found between ELISA and CLIA, suggesting the importance of confirming results with a second assay.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Article Immunology

High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris

Francois Anna et al.

Summary: This study conducted in Paris conurbation found that the prevalence of SARS-CoV-2 infection in active workers was approximately 11.6% in May-July 2020, higher than laboratory testing positivity rates. The research also indicated that some infected individuals did not exhibit systemic IgG responses, suggesting that the true infection rate may have reached 16.6%, with anosmia and ageusia being common symptoms of infection.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy

Roberto Berte et al.

Summary: The seroprevalence of SARS-CoV-2 in IBD patients treated with biologic therapy reflects values measured in the local general population. Specific symptoms and contact history with SARS-CoV-2-infected individuals strongly increase the likelihood of SARS-CoV-2 seropositivity.

JOURNAL OF CROHNS & COLITIS (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave

Eric R. A. Vos et al.

Summary: During the first epidemic wave, the overall seroprevalence of SARS-CoV-2 in the Netherlands was estimated to be 2.8%, with the highest rates among 18-39 year-olds and the lowest among children aged 2-17. Those taking immunosuppressants and individuals from the Orthodox-Reformed Protestant community had higher odds of being seropositive. Anosmia/ageusia was the most discriminative symptom between seropositive and seronegative individuals.

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic

E. Dickson et al.

Summary: The study estimated the seroprevalence of SARS-CoV-2 antibodies in the general population of Scotland, finding a rate of 4.3% over the study period. The proportion varied between 1.9% and 6.8% each week with no significant differences by age, sex, or geographical area.

PUBLIC HEALTH (2021)

Add to Collection

Article Infectious Diseases

Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study

Sebastian Weis et al.

Summary: The CoNAN study aimed to assess SARS-CoV-2 antibody seroprevalence using six different IgG-detecting immunoassays, and investigate potential risk factors for symptomatic versus asymptomatic coronavirus disease 2019 courses. The study found that antibody-positive participants with symptoms had significantly higher antibody levels than asymptomatic participants, but no persisting viral replication was detected.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Review Public, Environmental & Occupational Health

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis

Xinhua Chen et al.

Summary: This study synthesized and evaluated a large amount of global data on SARS-CoV-2 serological surveys, revealing variations in seroprevalence among different populations and in the infection-to-case ratio across regions. Most settings have not achieved herd immunity, and insights into the true proportion of infected population can be derived from serological detection data in routine confirmation.

LANCET GLOBAL HEALTH (2021)

Add to Collection

Editorial Material Public, Environmental & Occupational Health

COVID-19 serosurveys for public health decision making

Manoj V. Murhekar et al.

LANCET GLOBAL HEALTH (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study

Thomas Roederer et al.

Summary: Between June 23 and July 2, 2020, a seroprevalence study conducted at 14 sites in Paris and Seine-Saint-Denis in the Ile-de-France region found that 52% of the 818 individuals recruited tested positive for COVID-19 antibodies. Seroprevalences varied significantly by type of recruitment site, with the highest in workers' residences (88.7%), followed by emergency shelters (50.5%), and food distribution sites (27.8%). Over two thirds of COVID-19 seropositive individuals did not report any symptoms during the recall period, and living in crowded conditions was strongly associated with exposure level.

LANCET PUBLIC HEALTH (2021)

Add to Collection

Article Infectious Diseases

Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study

Paola Stefanelli et al.

Summary: The seroprevalence study in northeastern Italy revealed a 23% prevalence of SARS-CoV-2 antibodies, three times higher than officially reported cases. The highest prevalence was in the 40-49 age group, and symptoms like anosmia and ageusia were strongly associated with seropositivity.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Article Infectious Diseases

SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020

Arnaud Fontanet et al.

Summary: The study conducted in schools in northern France suggests that children may play an important role in the transmission of SARS-CoV-2, with viral circulation identified in many schools. Enhanced control measures and surveillance in schools are needed to reduce the risk of transmission.

EUROSURVEILLANCE (2021)

Add to Collection

Article Medicine, General & Internal

Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden

X. Castro Dopico et al.

Summary: Before the mass vaccination started, a study in Stockholm revealed that approximately 15% of individuals surveyed by December 13, 2020 tested positive, increasing to 19% by the end of February 2021. Notably, 96% of seropositive healthy donors developed neutralizing antibody responses comparable to those seen in clinical trials of SARS-CoV-2 mRNA vaccines, indicating a competent B-cell response from mild infections.

JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

WHO International Standard for anti-SARS-CoV-2 immunoglobulin

Paul A. Kristiansen et al.

LANCET (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany

N. Ahmad Aziz et al.

Summary: The study conducted in Bonn, Germany examined the seroprevalence and temporal course of SARS-CoV-2 neutralizing antibodies, revealing a low prevalence (<1%) and a relatively rapid waning of neutralizing antibodies within a few months after the first epidemic wave. Only about 20% of individuals with positive neutralizing antibodies lost them within five months. Further population-based studies are needed to understand immunity levels and antibody dynamics.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Medicine, General & Internal

Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools

Agne Ulyte et al.

Summary: This study examined longitudinal changes in SARS-CoV-2 seroprevalence and clustering of seropositive children in schools in Zurich, Switzerland from June to November 2020. The overall seroprevalence increased during this period, with varying rates across districts. The clustering of seropositive children was observed in only a few classes, indicating that with schools open and preventive measures in place, transmission of SARS-CoV-2 among children was limited despite community transmission.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Editorial Material Infectious Diseases

Kinetics and seroprevalence of SARS-CoV-2 antibodies in children

Cathal Roarty et al.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Review Multidisciplinary Sciences

Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis

Niklas Bobrovitz et al.

Summary: A systematic review and meta-analysis of 968 seroprevalence studies with 9.3 million participants from 74 countries found significant variations in SARS-CoV-2 antibody prevalence among different populations. Ethnic minorities and certain age groups were more likely to test positive for antibodies. National studies reported lower seroprevalence estimates compared to regional and local studies, with considerable variation across regions.

PLOS ONE (2021)

Add to Collection

Article Immunology

Evidence for antibody as a protective correlate for COVID-19 vaccines

Kristen A. Earle et al.

Summary: The study found a strong correlation between antibody titers and efficacy when assessing different COVID-19 vaccines, supporting the use of post-immunization antibody titers as the basis for establishing a correlate of protection for COVID-19 vaccines.

VACCINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance

Stephane Le Vu et al.

Summary: The study reports the estimated seroprevalence in the French population during the first wave of COVID-19, as well as the proportion of infected individuals who developed neutralising antibodies at three points throughout this period. The results show a gradual increase in nationwide seroprevalence, with approximately 70% of seropositive individuals having neutralising antibodies, and an infection fatality rate that increases exponentially with age.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2

Niclas Roxhed et al.

Summary: Researchers have developed a multiplexed approach to screen IgG and IgM levels against several SARS-CoV-2 proteins in home-sampled dried blood spots and estimated a seroprevalence of 12.5% in Stockholm in spring of 2020.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study

Anton Barchuk et al.

Summary: A seroprevalence study of SARS-CoV-2 antibodies in Saint Petersburg, Russia showed that correcting for non-response bias resulted in lower estimates, with factors such as history of illnesses, COVID-19 testing, smoking status, allergies, and hand-washing habits playing a role in seroconversion. This suggests that even low estimates of seroprevalence may be overestimations, and serosurvey designs should consider characteristics associated with participation and seropositivity.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2-Specific Antibody Prevalence and Symptoms in a Local Austrian Population

Dennis Ladage et al.

Summary: This study investigated the prevalence of SARS-CoV-2 antibodies in a high-incidence Austrian town and found that 9% of the population carried the antibodies, higher than the 6% in neighboring villages. 20% of antibody carriers reported being asymptomatic, while specific combinations of symptoms were found to have high prognostic value for predicting infection.

FRONTIERS IN MEDICINE (2021)

Add to Collection

Article Obstetrics & Gynecology

SARS-COV-2 IgG antibody response in pregnant women at delivery

Vassilis Tsatsaris et al.

Summary: The prevalence of SARS-CoV-2 IgG in pregnant women at the time of delivery in Paris four months after the beginning of the infection is low, at 4.7%. Studies evaluating the impact of COVID-19 infection during pregnancy should take this information into account in order to adjust the sample size.

JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2021)

Add to Collection

Article Pediatrics

Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study

Thomas Waterfield et al.

Summary: This study found that children had similar antibody responses to SARS-CoV-2 regardless of age, with fatigue, gastrointestinal symptoms, and changes in sense of smell or taste being the symptoms most strongly associated with SARS-CoV-2 antibody positivity.

ARCHIVES OF DISEASE IN CHILDHOOD (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among hospital workers in a severely affected institution in Madrid, Spain: A surveillance cross-sectional study

Felipe Perez-Garcia et al.

Summary: The study analyzed the impact of the COVID-19 pandemic on workers in a hospital in Spain and found that over 36% of the workers were infected with SARS-CoV-2, with nearly 32% being asymptomatic. The use of personal protective equipment and previous contacts with COVID-19 patients were identified as key factors associated with SARS-CoV-2 infection.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2021)

Add to Collection

Article Primary Health Care

Community seroprevalence of COVID-19 in probable and possible cases at primary health care centres in Spain

Patricia Montenegro et al.

Summary: This study aimed to measure the seroprevalence of antibodies against SARS-CoV-2 infection in a community sample of possible cases and among probable cases followed in primary care. The results showed that the seroprevalence of antibodies among possible cases was lower than expected, while approximately 40% of symptomatic patients followed up by GPs during the peak months of the pandemic were positive.

FAMILY PRACTICE (2021)

Add to Collection

Review Medicine, General & Internal

Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2 A Narrative Review

Matthew P. Cheng et al.

ANNALS OF INTERNAL MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Screening of Mothers in a COVID-19 Low-Prevalence Region: Determination of SARS-CoV-2 Antibodies in 401 Mothers from Rostock by ELISA and Confirmation by Immunofluorescence

Emil C. Reisinger et al.

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2020)

Add to Collection

Article Infectious Diseases

Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020

Elena Percivalle et al.

EUROSURVEILLANCE (2020)

Add to Collection

Article Infectious Diseases

SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020

Bastian Fischer et al.

EUROSURVEILLANCE (2020)

Add to Collection

Article Infectious Diseases

Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020

Zacharoula Bogogiannidou et al.

EUROSURVEILLANCE (2020)

Add to Collection

Article Geriatrics & Gerontology

Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary

Bela Merkely et al.

GEROSCIENCE (2020)

Add to Collection

Meeting Abstract Oncology

Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy

A. Zambelli et al.

ANNALS OF ONCOLOGY (2020)

Add to Collection

Article Urology & Nephrology

High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening

Candice Clarke et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Add to Collection

Article Pharmacology & Pharmacy

Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors

Pierre Gallian et al.

ANTIVIRAL RESEARCH (2020)

Add to Collection

Article Medicine, General & Internal

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Marina Pollan et al.

LANCET (2020)

Add to Collection

Article Infectious Diseases

SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020

Sheila F. Lumley et al.

EUROSURVEILLANCE (2020)

Add to Collection

Article Infectious Diseases

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020

Craig P. Thompson et al.

EUROSURVEILLANCE (2020)

Add to Collection

Article Obstetrics & Gynecology

RISK FACTOR ANALYSIS FOR SARS-COV-2 SEROPOSITIVITY WITHIN ASSISTED REPRODUCTIVE

Nicolás Prados et al.

FERTILITY AND STERILITY (2020)

Add to Collection

News Item Medicine, General & Internal

Covid-19: US cases are greatly underestimated, seroprevalence studies suggest

Janice Hopkins Tanne

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Review Medicine, General & Internal

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis

Mayara Lisboa Bastos et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Article Infectious Diseases

Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England

Philippa M. Wells et al.

JOURNAL OF INFECTION (2020)

Add to Collection

Letter Infectious Diseases

Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening

Gabriele Pagani et al.

JOURNAL OF INFECTION (2020)

Add to Collection

Article Multidisciplinary Sciences

Post lockdown COVID-19 seroprevalence and circulation at the time of delivery, France

Jeremie Mattern et al.

PLOS ONE (2020)

Add to Collection

Review Multidisciplinary Sciences

What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors

Wee Chian Koh et al.

PLOS ONE (2020)

Add to Collection

Article Cell Biology

A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations

Ludivine Grzelak et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Prevalence of asymptomatic SARS-CoV-2-positive individuals in the general population of northern Italy and evaluation of a diagnostic serological ELISA test: a cross-sectional study protocol

Massimo Guerriero et al.

BMJ OPEN (2020)

Add to Collection

Article Medicine, General & Internal

Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis

Diana Buitrago-Garcia et al.

PLOS MEDICINE (2020)

Add to Collection

Article Microbiology

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

Jeffrey Seow et al.

NATURE MICROBIOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors

Antonio Vena et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Prevalence of Current and Past SARS-CoV-2 Infections among Police Employees in Poland, June-July 2020

Mariusz Gujski et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Low Seroprevalence of SARS-CoV-2 Antibodies during Systematic Antibody Screening and Serum Responses in Patients after COVID-19 in a German Transplant Center

Mira Choi et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Article Biology

Seroprevalence of Antibodies against SARS-CoV-2 among the Personnel and Students of the National and Kapodistrian University of Athens, Greece: A Preliminary Report

Ourania E. Tsitsilonis et al.

Life-Basel (2020)

Add to Collection

Article Infectious Diseases

Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020

Claudia Santos-Hoevener et al.

EUROSURVEILLANCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy

Valeria Cento et al.

PLOS ONE (2020)

Add to Collection

Article Multidisciplinary Sciences

Seroprevalence analysis of SARS-CoV-2 in pregnant women along the first pandemic outbreak and perinatal outcome

Cecilia Villalain et al.

PLOS ONE (2020)

Add to Collection

Article Multidisciplinary Sciences

Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany

Hendrik Streeck et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Medicine, General & Internal

Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg

Nicola Capasso et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Article Immunology

SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy)

Vieri Lastrucci et al.

VACCINES (2020)

Add to Collection

Letter Urology & Nephrology

Detection of SARS-CoV-2 Antibodies in Kidney Transplant Recipients

Maria Prendecki et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Seroprevalence of SARS-Cov-2 in the setting of a non-dedicated COVID-19 hospital in a low CoV-2 incidence area: Implications for surgery

Fabio Medas et al.

ANNALS OF MEDICINE AND SURGERY (2020)

Add to Collection

Article Pediatrics

Searching for COVID-19 Antibodies in Czech Children-A Needle in the Haystack

Marketa Bloomfield et al.

FRONTIERS IN PEDIATRICS (2020)

Add to Collection

Article Multidisciplinary Sciences

Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands

Ed Slot et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Infectious Diseases

Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study

Ania Wajnberg et al.

LANCET MICROBE (2020)

Add to Collection

Letter Immunology

Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands

Maria Skaalum Petersen et al.

EMERGING INFECTIOUS DISEASES (2020)

Add to Collection

Review Oncology

Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data

Luis Cabezon-Gutierrez et al.

CANCER TREATMENT REVIEWS (2020)

Add to Collection

Article Medicine, General & Internal

Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020

Lisandru Capai et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Article Microbiology

A COVID-19 Hotspot Area: Activities and Epidemiological Findings

Francesca Cito et al.

MICROORGANISMS (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

SARS-CoV-2: seroepidemiological pattern in northeastern Bulgaria

Denitsa Tsaneva-Damyanova

BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT (2020)

Add to Collection

Article Medical Laboratory Technology

Prevalence of Severe Acute Respiratory Syndrome Coronavirus-2-specific Antibodies in German Blood Donors during the COVID-19 Pandemic

Stefan Runkel et al.

CLINICAL LABORATORY (2020)

Add to Collection

Article Hematology

Comparison of donor and general population demographics over time: a BEST Collaborative group study

Mindy Goldman et al.

TRANSFUSION (2017)

Add to Collection

Review Medicine, General & Internal

Rayyan-a web and mobile app for systematic reviews

Mourad Ouzzani et al.

SYSTEMATIC REVIEWS (2016)

Add to Collection

© Peeref 2019-2024. All rights reserved.